Tango Therapeutics is a growing cancer drug development company with partners such as Gilead Sciences. Explore more details ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval ...

“There’s always an energy behind the ball,” Gilgeous-Alexander said after OKC’s 113-105 win, its 12th straight, Tuesday night at Paycom Center to close out 2024. “Kind of spiritual. There’s always a ...

"We are pioneering the RNA editing field with unmatched platform capabilities and a growing pipeline of innovative GalNAc programs for cardiometabolic diseases. We have also translated our ...

Entering 2025 having demonstrated rapid translation of genetic insights to positive clinical data; advancing clinically validated and multi-modal ...

BD (Becton, Dickinson and Company) , a leading global medical technology company, announced today that Pamela Spikner has ...

This partnership is viewed as crucial for the anticipated commercial launch of Arrowhead's first RNA interference therapeutic in 2026, pending approval. Arrowhead's lead program, plozasiran ...

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview and participate in a Q&A session at the 43rd Annual ...

KVS Class 12 Sample Practice Paper 2024-25: The Central Board of Secondary Education (CBSE) Class 12 exams are planned to start from February 15, 2025. It is the time when students should practice ...